Lung liquid production by in vitro lungs from fetal guinea pigs: studies with metabolic inhibitors.
Lungs from fetal guinea pigs (62 +/- 2 days of gestation) were supported in vitro for 3 h, and lung liquid production was measured by dye dilution. Eighteen untreated preparations produced fluid at 1.76 +/- 0.30 mL.kg-1 body weight.h-1 during the first hour, with no significant changes in later hours. When inhibitors of respiratory processes were placed in the outer saline during the middle hour, production changed significantly, as follows: (a) sodium iodoacetate at 10(-3) M stopped production (87.2 +/- 10.3 and 100% reductions, successive hours; n = 6), at 10(-4) M it reduced production (60.0 +/- 10.3 and 63.4 +/- 9.3% reduction, successive hours; n = 12); (b) sodium fluoride, 10(-3) M, almost stopped production (93.2 +/- 12.1 and 89.5 +/- 9.3% reductions, successive hours; n = 6); (c) sodium cyanide at high concentration (10(-3) M) reduced production slowly (35.5 +/- 12.3 and 73.1 +/- 22.4%; successive hours; n = 6); (d) sodium azide, 10(-3) M, also reduced production (67.6 +/- 14.2 and 59.7 +/- 14.0%, successive hours; n = 6); total lactate lost rose 1.8 +/- 0.5 fold; (e) dinitrophenol produced strong reabsorptions; at 10(-3) M, production fell 115.4 +/- 15.9 and 113.1 +/- 47.3%, successive hours (n = 4), and at 2 x 10(-4) M it fell 143.8 +/- 33.8 and 153.4 +/- 26.7%, successive hours (n = 6); total lactate lost rose 2- to 3-fold. Control preparations showed no significant changes. The results suggest that lung liquid production requires glycolysis and aerobic metabolism. However, reabsorption appears to continue on glycolysis alone, a particularly useful situation for neonates suffering respiratory distress.
Perks
A M
AM
Department of Zoology, University of British Columbia, Vancouver, Canada.
Ruiz
T
T
Vanderhorst
E
E
D000818:Animals; D001826:Body Fluids / Q000378:metabolism* / Q000502:physiology; D003580:Cytochromes / Q000037:antagonists & inhibitors; D005314:Embryonic and Fetal Development / Q000187:drug effects; D004734:Energy Metabolism / Q000187:drug effects*; D006168:Guinea Pigs; D066298:In Vitro Techniques; D007461:Iodoacetates / Q000494:pharmacology; D019807:Iodoacetic Acid; D008168:Lung / Q000196:embryology / Q000378:metabolism*; D010085:Oxidative Phosphorylation / Q000187:drug effects; D012969:Sodium Fluoride / Q000494:pharmacology
D003580:Cytochromes; D007461:Iodoacetates; D012969:Sodium Fluoride; D019807:Iodoacetic Acid